JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB82477

Anti-Adenosine A1 Receptor antibody

3

(2 Reviews)

|

(37 Publications)

Rabbit Polyclonal Adenosine A1 Receptor antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Rat, Mouse samples. Cited in 37 publications.

View Alternative Names

Adenosine receptor A1

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Adenosine A1 Receptor antibody (AB82477)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Adenosine A1 Receptor antibody (AB82477)

IHC image of ab82477 staining in Rat Adult Brain formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab82477, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Immunocytochemistry/ Immunofluorescence - Anti-Adenosine A1 Receptor antibody (AB82477)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Adenosine A1 Receptor antibody (AB82477)

ICC/IF image of ab82477 stained PC12 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab82477, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM. This antibody also gave a positive result in 4% PFA fixed (10 min) PC12 cells at 5µg/ml.

Western blot - Anti-Adenosine A1 Receptor antibody (AB82477)
  • WB

Unknown

Western blot - Anti-Adenosine A1 Receptor antibody (AB82477)

All lanes:

Western blot - Anti-Adenosine A1 Receptor antibody (ab82477) at 1 µg/mL

Lane 1:

Rat Spinal Ganglion Neuronal cell lysate at 10 µg

Lane 2:

Western blot - EL4 whole cell lysate (<a href='/en-us/products/cell-lysates/el4-whole-cell-lysate-ab7183'>ab7183</a>) at 10 µg

Secondary

All lanes:

Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size: 37 kDa

Observed band size: 118 kDa,18 kDa,36 kDa

true

Exposure time: 1min

Western blot - Anti-Adenosine A1 Receptor antibody (AB82477)
  • WB

CiteAb

Western blot - Anti-Adenosine A1 Receptor antibody (AB82477)

Adenosine A1 Receptor western blot using anti-Adenosine A1 Receptor antibody ab82477. Publication image and figure legend from Zhai, W., Chen, D., et al., 2016, Mol Brain, PubMed 27301321.

ab82477 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab82477 please see the product overview.

Changes in adenosine receptor expression in vivo and in vitro. a Western blot analysis of adenosine receptor expression at different time points following ICH in vivo. A1AR levels peaked at 48 h. b Quantification of the results in panel A. Bars represent relative protein levels. The mean values of the protein levels in the sham group were normalized to 1.0. *p < 0.05 for the 48 h ICH group versus the sham group. c Western blots of adenosine receptor expression in vitro. A1AR levels peaked at 48 h. d Quantification of the results in panel C. Bars represents relative protein levels. The mean values of the protein levels in the control group were normalized to 1.0. *p < 0.05 for the 48 h OxyHb group versus the control group. e and f Immunofluorescence in vivo. Double immunofluorescence analysis was performed with A1AR antibodies (green) and neuronal or astrocyte marker (NeuN/GFAP, red), and nuclei were fluorescently labeled with DAPI (blue). Scale bar = 32 μm. G : Immunofluorescence in vitro. Double immunofluorescence analysis was performed with A1AR antibodies (green) and neuronal marker (NeuN, red), and nuclei were fluorescently labeled with DAPI (blue). Scale bar = 20 μm

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat

Applications

WB, ICC/IF, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

Replenishment batches of ab82477 are tested in WB. Previous batches were additionally validated in ICC/IF and IHC-P. These applications are still expected to work and are covered by our Abpromise guarantee.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1 µg/mL", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Adenosine A1 Receptor also called A1 adenosine receptor is a G protein-coupled receptor (GPCR) with a mass of approximately 37 kDa. This receptor is primarily responsible for binding adenosine a nucleoside involved in numerous physiological processes. Mechanically the A1 receptor inhibits adenylyl cyclase activity via the Gi/o proteins resulting in decreased intracellular cyclic AMP levels. This receptor is expressed in various tissues including the brain heart and kidneys indicating its widespread physiological roles.
Biological function summary

The A1 receptor plays a significant role in mediating the inhibitory effects of adenosine on neurotransmitter release. It regulates synaptic transmission modulates excitability and protects tissues from excessive stimulation. This receptor does not function alone but is part of complex networks interacting with other proteins such as A2A receptors. A1 adenosine receptor signaling contributes to cardioprotection neuroprotection and regulation of renal blood flow reflecting its importance in maintaining homeostasis.

Pathways

The A1 receptor is essential in the adenosine signaling pathway and myocardial protection pathway. Through these pathways it influences important physiological responses like heart rate and blood flow. It interacts with proteins such as adenosine kinase and adenosine deaminase which regulate adenosine concentration influencing the availability of adenosine for receptor binding. The pathways involved illustrate the receptor's role in balancing energy supply and demand.

The A1 adenosine receptor is implicated in conditions like cardiac arrhythmias and epilepsy. Its role in reducing excitability and modulating synaptic transmission makes it a potential target for epilepsy treatment. In cardiac arrhythmias it helps regulate heart rate and protects against ischemic damage. The receptor's interactions with A2B receptors emphasize its role in complex disease mechanisms where it balances excitatory and inhibitory signals providing opportunities for therapeutic interventions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Receptor for adenosine. The activity of this receptor is mediated by G proteins such as GNAI2 which inhibit adenylyl cyclase (By similarity).
See full target information Adora1

Publications (37)

Recent publications for all applications. Explore the full list and refine your search

Molecules (Basel, Switzerland) 30: PubMed40733187

2025

The Role of Adenosine A1 and A2a Receptors in Cerebral Blood Vessel Reactivity of Sprague Dawley Rats Exposed to Hyperbaric Oxygenation.

Applications

Unspecified application

Species

Unspecified reactive species

Vedran Đambić,Zrinka Mihaljević,Ines Drenjančević,Ivana Jukić,Petar Šušnjara,Aleksandar Kibel

Cureus 16:e75926 PubMed39830563

2025

Role of Adenosine A1 Receptor in Sleep Deprivation-Induced Neuroinflammation: Insights on Rapid Eye Movement Sleep and Fear Extinction Memory Recall in Rats.

Applications

Unspecified application

Species

Unspecified reactive species

Bhanuteja Thondala,Garima Chauhan,Harsh Pawar,Koushik Ray,Monika Sharma,Neha Yadav,Sanjeev Kumar,Krishna Kishore,Usha Panjwani

Pharmaceutical biology 62:456-471 PubMed38773737

2024

Network pharmacology integrated with experimental validation to elucidate the mechanisms of action of the Guizhi-Gancao Decoction in the treatment of phenylephrine-induced cardiac hypertrophy.

Applications

Unspecified application

Species

Unspecified reactive species

Kaijing Yang,Xiaoli Shan,Yang Songru,Mengwei Fu,Pei Zhao,Wei Guo,Ming Xu,Huihua Chen,Rong Lu,Chen Zhang

CNS neuroscience & therapeutics 30:e14726 PubMed38715251

2024

Astrocytes in preoptic area regulate acute nociception-induced hypothermia through adenosine receptors.

Applications

Unspecified application

Species

Unspecified reactive species

Junke Jia,Ting Chen,Chang Chen,Tengxiao Si,Chenyi Gao,Yuanyuan Fang,Jiahui Sun,Jie Wang,Zongze Zhang

Cell reports. Medicine 5:101477 PubMed38508143

2024

Activation of hepatic adenosine A1 receptor ameliorates MASH via inhibiting SREBPs maturation.

Applications

Unspecified application

Species

Unspecified reactive species

Weize Zhu,Ying Hong,Zhaowei Tong,Xiaofang He,Yan Li,Hao Wang,Xinxin Gao,Pengtao Song,Xianshan Zhang,Xiaochang Wu,Zhenhua Tan,Wenjin Huang,Zekun Liu,Yiyang Bao,Junli Ma,Ningning Zheng,Cen Xie,Xisong Ke,Wen Zhou,Wei Jia,Mingxiao Li,Jing Zhong,Lili Sheng,Houkai Li

Animal nutrition (Zhongguo xu mu shou yi xue hui) 13:282-288 PubMed37168450

2023

Dietary adenosine supplementation improves placental angiogenesis in IUGR piglets by up-regulating adenosine A2a receptor.

Applications

Unspecified application

Species

Unspecified reactive species

Zifang Wu,Jiawei Nie,Deyuan Wu,Shuangbo Huang,Jianzhao Chen,Huajin Liang,Xiangyu Hao,Li Feng,Hefeng Luo,Chengquan Tan

Biomedicines 10: PubMed36359350

2022

Adenosine Receptors Profile in Fibromuscular Dysplasia.

Applications

Unspecified application

Species

Unspecified reactive species

Claire Guiol,Sarah El Harake,Julien Fromonot,Mohamed Chefrour,Marguerite Gastaldi,Yassine Alibouch,Maxime Doublier,Pierre Deharo,Gabrielle Sarlon,Marion Marlinge,Nathalie Lalevee,Régis Guieu,François Silhol

Neural regeneration research 17:2504-2511 PubMed35535903

2022

Silencing miRNA-324-3p protects against cerebral ischemic injury via regulation of the GATA2/A1R axis.

Applications

Unspecified application

Species

Unspecified reactive species

An-Qi Zhang,Lu Wang,Yi-Xiu Wang,Shan-Shan Hong,Yu-Shan Zhong,Ru-Yi Yu,Xin-Lu Wu,Bing-Bing Zhou,Qi-Min Yu,Hai-Feng Fu,Shuang-Dong Chen,Yun-Chang Mo,Qin-Xue Dai,Jun-Lu Wang

Frontiers in cellular neuroscience 15:783478 PubMed35002628

2021

Cordycepin Ameliorates Synaptic Dysfunction and Dendrite Morphology Damage of Hippocampal CA1 A1R in Cerebral Ischemia.

Applications

Unspecified application

Species

Unspecified reactive species

Zhao-Hui Chen,Yuan-Yuan Han,Ying-Jie Shang,Si-Yi Zhuang,Jun-Ni Huang,Bao-Yan Wu,Chu-Hua Li

Frontiers in cardiovascular medicine 8:761164 PubMed34805317

2021

A Adenosine Receptor Subtypes Overproduction in Atria of Perioperative Atrial Fibrillation Patients Undergoing Cardiac Surgery: A Pilot Study.

Applications

Unspecified application

Species

Unspecified reactive species

Baptiste Maille,Julien Fromonot,Claire Guiol,Marion Marlinge,Florian Baptiste,Suzy Lim,Charlotte Colombani,Marie Charlotte Chaptal,Mohamed Chefrour,Marguerite Gastaldi,Frederic Franceschi,Jean-Claude Deharo,Vlad Gariboldi,Jean Ruf,Giovanna Mottola,Régis Guieu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com